Navigation Links
Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
Date:10/29/2007

LOS ANGELES, Calif., Oct. 29 /PRNewswire/ -- Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

In the Elekta booth, Jay Hoey, Executive Vice President Product Creation at Elekta and CEO of IMPAC Medical Systems, announced the new Elekta Infinity, which more precisely targets tumors and protects surrounding healthy tissue, while drastically reducing radiation therapy treatment times.

"Elekta is committed to fighting serious disease and improving quality of life," says Hoey. "The Elekta Infinity with VMAT demonstrates this by benefiting patients with dramatically shorter treatment times and highly precise tumor targeting."

Elekta VMAT improves on IMRT technology

Utilizing Elekta's VMAT solution greatly improves on existing IMRT technologies and offers a faster alternative to helical tomotherapy. Elekta's VMAT solution, when used with Elekta Infinity, varies the radiation beam during treatment by simultaneously manipulating the gantry position and speed, MLC leaves, dose rate and collimator angle.

This provides several distinct advantages over current IMRT techniques, specifically the ability to deliver more radiation to the target while sparing healthy tissue in significantly less time than existing therapies. In addition, Elekta Infinity combines VMAT with VolumeView(TM) 3D cone beam imaging to create high-co
'/>"/>

SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... to $5.8 million and provides a good start to Q4.  The ... America and one in the Middle East ... record levels," said Peter Bruijns , President & CEO. "Total ... Q3 than they have been for any complete year since the ...
(Date:10/20/2014)... PLAINSBORO, N.J. (PRWEB) October 20, 2014 ... that the Sidney Kimmel Cancer Center at Thomas ... program. , Through the Strategic Alliance Partnership ... and OncLive will collaborate to raise awareness of ... cancer treatment, and other projects. Clinicians and other ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The 9th Annual ... take place at the Congress Center Basel, ... now available at http://www.abim.ch . ... from all over the globe will exchange ... products and developments on the world market. ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... PRXL ), a leading global biopharmaceutical services,organization, ... Goldberg, M.D.,to Chief Operating Officer (COO). Dr. Goldberg ... Perceptive Informatics at,PAREXEL. He will continue to oversee ... von Rickenbach, Chairman and Chief Executive Officer of ...
... Sagent Pharmaceuticals, Inc.,a privately-held specialty pharmaceutical company, today ... USP, and cefuroxime for,injection, USP, two broad spectrum ... Sagent,s ceftriaxone for,injection will be available to the ... single,dose vials, as well as 1g and 2g ...
... PALO ALTO, Calif., July 16 Jazz,Pharmaceuticals, Inc. ... has entered,into definitive agreements with selected investors to ... of (i) one share of the Company,s,common stock, ... (ii) a,warrant to purchase 0.45 of a share ...
Cached Biology Technology:PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 2PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 3PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 4Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP 2Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP 3Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering 2Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering 3
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... thieves, prostate cancer tumors scavenge and hoard copper that ... avarice may be a fatal weakness. , Researchers ... prostate cancer cells by delivering a trove of copper ... cells brimming with the mineral, leaving non-cancer cells healthy. ... commercially available for other uses, could soon be tested ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Prostate cancer's penchant for copper may be a fatal flaw 2
... have devised a means of identifying partial, distorted, scratched, ... seconds. Previous techniques have tried to identify a ... match them against a database of templates. The University ... each print and transform the topological pattern into a ...
... issue of G&D, Dr. Guillermo Oliver (St. ... evidence to resolve a century-old debate over the ... development of the lymphatic vasculature is integral to ... and maintaining tissue fluid levels) and disease (lymphedema ...
... Acid rain was one of the worlds worst pollution problems ... Britain, as well as Europe and North America. In ... been acidified, harming fish, stream insects and river birds such ... has been taken across Europe to clean up acid pollutants ...
Cached Biology News:New technology identifies warped fingerprints at warp speed 2Recovery from acid rain 'much slower than expected' 2
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
...
Biology Products: